SCHEMBL5199727

SCHEMBL5199727

NC(CC1CCCC1)C1CC1

nearest known ligand 0.52

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 2/20 0.33
EPHX1 P07099 1/20 0.33
METAP1 P53582 1/20 0.32
ALOX5 P09917 2/20 0.32
TP53 P04637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19982053 1.00 DPP4 (0.33) DPP4EPHX1METAP1ALOX5TP53
SCHEMBL23022847 0.97 EPHX1 (0.37) DPP4EPHX1METAP1ALOX5TP53
SCHEMBL19982043 0.97 EPHX1 (0.37) DPP4EPHX1METAP1ALOX5TP53
SCHEMBL12960415 0.89
SCHEMBL16512120 0.80 ALDH1A1 (0.38) EPHX1TP53
SCHEMBL18827772 0.77 ACHE (0.32)
SCHEMBL3670488 0.75
SCHEMBL3680720 0.72 SIGMAR1 (0.42) DPP4EPHX1METAP1ALOX5
SCHEMBL10305516 0.72 DPP4 (0.43) DPP4EPHX1METAP1ALOX5
SCHEMBL453071 0.72 SIGMAR1 (0.42) DPP4EPHX1METAP1ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1737823-A2 NOVEL ALKYNE COMPOUNDS WITH AN MCH-ANTAGONISTIC ACTION AND MEDICAMENTS COMPRISING SAID COMPOUNDS Boehringer Ingelheim International GmbH (DE) 2007-01-03 EP claimed
WO-2005103002-A2 NOVEL ALKYNE COMPOUNDS WITH AN MCH-ANTAGONISTIC ACTION AND MEDICAMENTS COMPRISING SAID COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2005-11-03 WO claimed
EP-1737823-A2 NOVEL ALKYNE COMPOUNDS WITH AN MCH-ANTAGONISTIC ACTION AND MEDICAMENTS COMPRISING SAID COMPOUNDS Boehringer Ingelheim International GmbH (DE) 2007-01-03 EP disclosed
WO-2005103002-A2 NOVEL ALKYNE COMPOUNDS WITH AN MCH-ANTAGONISTIC ACTION AND MEDICAMENTS COMPRISING SAID COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2005-11-03 WO disclosed